Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Mayo Clinic
Mayo Clinic
Eastern Cooperative Oncology Group
Neonc Technologies, Inc.
ViroMissile, Inc.
Bristol-Myers Squibb
Kaiser Permanente
AstraZeneca
Tizona Therapeutics, Inc
Genentech, Inc.
Jonsson Comprehensive Cancer Center
MacroGenics
Daiichi Sankyo
ImmunityBio, Inc.
Ocellaris Pharma, Inc.
Fusion Pharmaceuticals Inc.
Innate Pharma
OncoNano Medicine, Inc.
City of Hope Medical Center
Mayo Clinic
University of Pittsburgh
HiFiBiO Therapeutics
DualityBio Inc.
TScan Therapeutics, Inc.
TScan Therapeutics, Inc.
University of Pittsburgh
UNC Lineberger Comprehensive Cancer Center
Incyte Corporation
Actym Therapeutics, Inc.
University of Arizona
Travera Inc
Pfizer
Arcus Biosciences, Inc.
Washington University School of Medicine
Incyte Corporation
Cancer Research UK
Institut Claudius Regaud
University of Virginia
Incyte Corporation
Marengo Therapeutics, Inc.
UNICANCER
Tempus AI
N.N. Petrov National Medical Research Center of Oncology
Turnstone Biologics, Corp.
Revolution Medicines, Inc.
Arbeitsgemeinschaft medikamentoese Tumortherapie
Bispebjerg Hospital
Seagen Inc.
Vall d'Hebron Institute of Oncology